Full-Time

Director of Market Intelligence & Strategic planning

Posted on 5/5/2025

Becton Dickinson

Becton Dickinson

10,001+ employees

Global medical technology and diagnostics provider

Compensation Overview

€108.6k - €195.5k/yr

Senior, Expert

Pont-de-Claix, France + 1 more

More locations: Midland Park, NJ, USA

Category
Business Research
Strategy Development
Business & Strategy
Required Skills
Power BI
Market Research
Marketing
Business Strategy
Data Analysis
Requirements
  • Bachelor’s degree or equivalent experience in Business, Marketing, Economics, or a related field (MBA preferred)
  • Proven experience in market research, competitive intelligence, strategy consulting, or a similar analytical role
  • Experience in management, leading people and developing talent
  • Strong expertise in research methodologies, data analytics, and business strategy
  • Capability to run strategic exercises for platforms / products (“process” expertise)
  • Experience with BI tools (Power BI) and market research platforms
  • Excellent interpersonal skills with the ability to influence senior partners
  • Proven track record of driving pivotal initiatives and delivering measurable business impact
  • High level of leadership and analytical skills, critical thinking, and ability to transform analysis into information and key recommendations for a leadership team
  • Strong intellectual curiosity and able to understand and assimilate sophisticated issues into understandable and actionable recommendations.
Responsibilities
  • Lead qualitative and quantitative market research initiatives to identify customer needs, industry trends, and emerging opportunities.
  • Develop and maintain a robust competitive intelligence program, analyzing competitor strategies, product positioning, and market dynamics.
  • Track macroeconomic, technological, and industry shifts that could impact business strategy.
  • Analyze and synthesize large datasets to uncover actionable insights for senior leadership.
  • Build predictive models and scenario planning frameworks to anticipate future market developments.
  • Work cross-functionally with product, sales, and finance teams to integrate market insights into decision-making.
  • Drive the ASR process for BDM-PS and support the annual strategic planning processes by delivering the Situation Analysis, Market sizing and its evolution over the coming years.
  • Collaborate with platforms and Global Marketing, to develop and refine the company’s long-term strategic roadmap, providing recommendations on market entry and expansion opportunities.
  • Present findings and strategic recommendations to the Unit LT and key partners.
  • Develop reports, dashboards, and presentations that translate sophisticated data into clear business narratives.
  • Nurture a culture of data-driven decision-making across the organization.
  • Connections with the investor relations group (and providing quarterly PS updates on business, pipeline, competition…Etc).

Becton Dickinson (BD) is a global medical technology company that enhances health through improved medical discovery, diagnostics, and care delivery. It serves hospitals, laboratories, and healthcare providers worldwide. BD operates in three segments: BD Medical, which focuses on medication management and delivery; BD Life Sciences, which offers products for safe collection and transport of diagnostic specimens; and BD Interventional, which provides devices for minimally invasive surgeries. BD generates revenue by selling medical devices, laboratory equipment, and diagnostic products. The company stands out from competitors by emphasizing innovation, quality, and customer service, with the goal of improving patient outcomes, reducing healthcare costs, and increasing safety and efficiency in healthcare.

Company Size

10,001+

Company Stage

IPO

Headquarters

Franklin Lakes, New Jersey

Founded

1961

Simplify Jobs

Simplify's Take

What believers are saying

  • BD's focus on digital health aligns with telemedicine and remote monitoring trends.
  • BD's investment in syringe manufacturing supports pandemic preparedness.
  • BD's acquisition of Tissuemed enhances its minimally invasive surgical solutions.

What critics are saying

  • Increased competition from companies like Abbott and Roche in digital health.
  • Potential regulatory challenges with new acquisitions like MedKeeper and Scanwell Health.
  • Supply chain vulnerabilities in sourcing raw materials for syringe manufacturing.

What makes Becton Dickinson unique

  • BD's acquisition of MedKeeper enhances its cloud-based pharmacy management capabilities.
  • BD's investment in syringe manufacturing aligns with global vaccination trends.
  • BD's acquisition of Cytognos expands its post-treatment monitoring capabilities.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Tuition Reimbursement

Company News

Slater Sentinel
Jan 4th, 2024
Affinity Wealth Management LLC Invests $2.18 Million in Becton, Dickinson and Company (NYSE:BDX)

Affinity Wealth Management LLC purchased a new stake in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 8,443 shares of the medical instruments supplier’s stock, valued at approximately $2,183,000. Other […]

PR Newswire
Jul 28th, 2022
BD Acquires MedKeeper to Offer Cloud-based, Connected Pharmacy Software

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired MedKeeper, a...

ROI-NJ
Jul 28th, 2022
Bd Acquires Medkeeper To Offer Cloud-Based, Connected Pharmacy Software

BD on Thursday said it acquired MedKeeper, a provider of modern, cloud-based pharmacy management applications. The acquisition adds to the Franklin Lakes-based company’s recent growth in high-technology pharmacy solutions and further accelerates its commitment to smart, connected care

PR Newswire
Feb 9th, 2022
Day Zero Diagnostics Announces Completion of $21M Financing

/PRNewswire/ -- Day Zero Diagnostics, Inc., an infectious disease diagnostics company harnessing the power of whole-genome sequencing and machine learning to...

PR Newswire
Feb 1st, 2022
BD Expands from Cancer Discovery and Diagnosis into Post-Treatment Monitoring with Acquisition of Cytognos from Vitro S.A.

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition...

INACTIVE